<DOC>
	<DOCNO>NCT01123187</DOCNO>
	<brief_summary>This single center phase 2 clinical trial , design confirm efficacy safety sequential islet allotransplantation steroid free immunosuppression patient previous kidney transplantation .</brief_summary>
	<brief_title>Islet Cell Transplantation Patients With Type I Diabetes With Previous Kidney Transplantation</brief_title>
	<detailed_description>The beneficial effect glycemic control survival function transplant kidney patient type 1 diabetes mellitus recognize . The purpose study reverse hyperglycemia insulin dependency , islet cell transplantation , patient type 1 diabetes mellitus stable kidney allograft . The study primary efficacy endpoint graft survival define insulin independence HbA1c &lt; 6.5 % 1 year post first transplant . Secondary outcome graft function metabolic control The immunosuppression protocol kidney graft convert sirolimus+tacrolimus regimen 6 month islet transplantation exclude negative effect kidney graft function .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Type 1 diabetes mellitus . Documentation negative basal stimulate Cpeptide diagnosis diabetes least 5 year . Recipient renal transplant good function ( creatinine clearance &gt; /=60 ml/min ) Stable immunosuppression consist combination sirolimus , tacrolimus least 6 month , without major complication Ability give inform consent . Age great equal 18 year less equal 65 year No evidence liver disease ( liver enzymes &lt; twice upper limit normal ) Age 18 year 65 year Significant cardiovascular disease , include noncorrectable coronary artery disease and/or recent myocardial infarction ( within last 12 month ) ; extensive peripheral vascular disease correctable surgery , unstable angina Untreated proliferative retinopathy . Recent Cerebrovascular accident ( within last 12 month ) Recent unresolved acute infection , chronic infection , include tuberculosis , HIV , HBV , HCV , CMV positive skin test TB Any history malignancy , except squamous basal skin cancer situ cancer cervix . History noncompliance , inability demonstrate capacity comply strict blood glycemic control insulin pump therapy . Psychiatric illness untreated , likely interfere significantly transplantation despite treatment . Pregnant woman , woman intend future pregnancy , woman reproductive potential unable unwilling follow effective contraceptive measure duration immunosuppressive therapy Fasting Cpeptide &gt; 0.2 ng/ml Creatinine &gt; 25mg/l Alkaline phosphatase , total bilirubin , Alanine Aminotransferase ( ALT ) Aspartate Aminotransferase ( AST ) &gt; twice upper limit normal Significant liver disease ( elevation liver enzymes &gt; twice upper limit normal ALT AST , liver mass include portal vein thrombosis , evidence portal hypertension , significant , untreated gallbladder disease ( i.e. , gallstone ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>diabetes type 1</keyword>
	<keyword>kidney transplantation</keyword>
	<keyword>islet</keyword>
	<keyword>hypoglycemia</keyword>
</DOC>